DOMINIC MAZZOCCHI: Open Payments
NPI 1679546501 · POINT PLEASANT BEACH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,913 in 174 payments from 26 companies in 2025. Trend: 2023 $6,219 · 2024 $3,192 · 2025 $3,913
Food & beverage: $3,913
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $727 |
| ABBVIE INC. | 39 | $566 |
| Novo Nordisk Inc | 14 | $316 |
| GlaxoSmithKline, LLC. | 12 | $308 |
| PFIZER INC. | 22 | $296 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $231 |
| Teva Pharmaceuticals USA, Inc. | 5 | $185 |
| Axsome Therapeutics, Inc. | 5 | $176 |
| Exact Sciences Corporation | 7 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $165 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, Ozempic, XIFAXAN, UBRELVY, AUSTEDO XR, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
